Thought Leadership
Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 5 of 12 posts
March 24, 2020 | Blog
Tumor-Agnostic Therapies: The Complex Path to Commercial Viability
The tumor-agnostic space is incredibly exciting and an area that is likely to be explored further. CBPartners’ blog post addresses the current precision medicine landscape, touching upon challenges, as well as key commercial considerations.
March 24, 2020 | Blog
Genome Editing: An Introduction
A topic that is becoming increasingly popular in the healthcare space is Genome Editing. CBPartners’ Cell and Gene Therapy Center of Excellence team explores the development of these technologies as they present an immense opportunity for the future of the pharmaceutical industry.
January 29, 2020 | Blog
Strategic Thinking: The Global Drug Launch Pricing Dilemma
Several factors contribute towards manufacturers seeking new ways to develop global drug pricing strategies. Product launches vary based on geography; when comparing the USA to EU, access outcomes can vary significantly based on whether or not the pivotal trial design has been optimized for each region.
May 20, 2019 | Research posters
ISPOR International 2019: Cross-Country ICER Evolution: What Does it Now Mean to be Cost-Effective?
ISPOR International 2019: CBPartners presented a poster to describe what it means to be cost-effective in an analysis of three different markets with HTA bodies that use CE analysis.
May 12, 2019 | Research posters
ISPOR International 2019: Value-Based Contracts – When and How Can They Actually Work?
ISPOR International 2019: CBPartners presented a poster which investigates how and when value-based-contracts (VBCs) can work effectively.